Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, & Asmaa Nafady. (2021). Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker. AOSIS.
Chicago Style (17th ed.) CitationAsmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, and Asmaa Nafady. Higher Proportion of Non-classical and Intermediate Monocytes in Newly Diagnosed Multiple Myeloma Patients in Egypt: A Possible Prognostic Marker. AOSIS, 2021.
MLA (9th ed.) CitationAsmaa M. Zahran, et al. Higher Proportion of Non-classical and Intermediate Monocytes in Newly Diagnosed Multiple Myeloma Patients in Egypt: A Possible Prognostic Marker. AOSIS, 2021.
Warning: These citations may not always be 100% accurate.